![Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial | Journal of Clinical Oncology Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2011.40.8666/asset/images/zlj9991028500005.jpeg)
Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial | Journal of Clinical Oncology
![Biomedicines | Free Full-Text | Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment Biomedicines | Free Full-Text | Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment](https://www.mdpi.com/biomedicines/biomedicines-11-00189/article_deploy/html/images/biomedicines-11-00189-g001.png)
Biomedicines | Free Full-Text | Cancer Stem Cell Relationship with Pro-Tumoral Inflammatory Microenvironment
![Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial | Journal of Clinical Oncology Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2011.40.8666/asset/images/zlj9991028500002.jpeg)